[{"path":"index.html","id":"about","chapter":"About","heading":"About","text":", Kishore Puthezhath MS Ortho, D Ortho, FACS (USA), FRCS (Tr & Orth)(Eng) Professor Orthopaedics KUHS. currently pursuing PhD orthopaedics research interests include fracture healing cross talk brain bone. lead Paediatric Orthopaedic Surgery tertiary teaching hospital Kerala.compilation represents collection notes insights gathered years, primarily focusing topics related Biometry, Orthopaedics, Medical Education, Health economics general experiences field. serves reflection journey learning areas, encapsulating technical aspects subjects practical experiences encountered.","code":""},{"path":"index.html","id":"contents","chapter":"About","heading":"Contents","text":"","code":""},{"path":"basic-science.html","id":"basic-science","chapter":"1 Basic Science","heading":"1 Basic Science","text":"","code":""},{"path":"basic-science.html","id":"bone-healing.","chapter":"1 Basic Science","heading":"1.1 Bone healing.","text":"Skeletal fracture occurs bone absorbs sufficient energy mechanical loading fail, resulting cortical discontinuity.Fracture healing biological process trabicular discontinuity bone restored. requires temporal coordinated action several different cell types, proteins expression hundreds genes working towards restoring structural integrity without scar formation.Fracture healing nothing reiterating embryonic endochondral bone formationFracture healing unique.Resulting bone microscopically macroscopically completely resembles present prior injury.Bone repair similar observed embryonic bone formation therefore truly regenerative process.essential difference bone healing healing tissue unlike tissue, bone heals scar.Cortical cancellous bone heal slightly different mechanisms. Interplay least four different factors identified can greatly effect process.StabilityThe scaffoldGrowth factorsOsteo-progenitor cells.basis Diamond concept healing discuss later.\nFigure 1.1: Diamond concept,fracture healing\ngiven chance heal minimal gap fractured ends, bone heals primary intention called primary healing. situations bigger gaps fractured ends, heal secondary intension, called secondary healing. effect gap fracture healing process due affect strain called fracture gap strain given formula ∆FGap/FGap described Perrin.Strain deformation material given force applied. Fracture gap stain ratio relative displacement fracture ends versus initial fracture gap width.Percentage strain determines type tissue formed healing. strain less-large fracture area (less ∆FGap)number fracture fragments.Less gap fracture fragments.Strain bone healingPercentage strain determines type tissue formed healing.","code":""},{"path":"basic-science.html","id":"primary-bone-healing.","chapter":"1 Basic Science","heading":"1.1.0.1 Primary bone healing.","text":"","code":""},{"path":"basic-science.html","id":"cortical-bone","chapter":"1 Basic Science","heading":"1.1.0.1.1 Cortical bone","text":"Cortical bone heals Osteonal remodeling Osteonal cutting cones gap. requiresabsolute stability (strain < 2%)gapViable bone ends\nFigure 1.2: Gap healing\ngap < 500µm, healing gap healing. gap healing, osteoblast lays sequential layers bone close gap.","code":""},{"path":"basic-science.html","id":"cancellous-bone.","chapter":"1 Basic Science","heading":"1.1.0.1.2 Cancellous bone.","text":"Heals primarily mechanism called bony ingrowth. revascularisation followed osteoblasts laying new bone.\nFigure 1.3: Bone ingrowth\nBone ingrowth cancellous bone","code":""},{"path":"basic-science.html","id":"secondary-bone-healing","chapter":"1 Basic Science","heading":"1.1.0.2 Secondary bone healing","text":"Ham 1930 published description early phases bone healing studying fractured rabbit fibulae ribs. Phases bone healing fully described McKibbin 1978. simple terms, bone heals 3 phases, like tissue.\nFigure 1.4: Secondary healing\n","code":""},{"path":"basic-science.html","id":"phases-of-bone-healing","chapter":"1 Basic Science","heading":"1.1.0.2.1 Phases of bone healing","text":"InflammationCellular proliferation differentiationRemodeling.However process complicated high specialisation calcified nature bone.Differentiation primitive mesenchymal stem cells cells osteogenic potential result specialized connective tissue formation called callus. Ambient strain stimulate fracture gaps form callus . strain environment 2%-10%. Bio-mechanical function callus reduce strain byincreasing diameter fractured area.Increasing stiffness.","code":""},{"path":"basic-science.html","id":"soft-and-hard-callus.","chapter":"1 Basic Science","heading":"1.1.0.2.2 Soft and Hard callus.","text":"Soft callus: Central, due endochondral ossification.Hard callus: Peripheral, due intramembranous ossification","code":""},{"path":"basic-science.html","id":"remodelling","chapter":"1 Basic Science","heading":"1.1.0.3 Remodelling","text":"2^0 process directed osteoclastic resorption * via howship lacunae metaphysis * via Osteons cortices. * Involves complex interplay RANK-RANKL\nFigure 1.5: RANK-RANKL\n","code":""},{"path":"adult-pathology.html","id":"adult-pathology","chapter":"2 Adult Pathology","heading":"2 Adult Pathology","text":"","code":""},{"path":"adult-pathology.html","id":"charcot","chapter":"2 Adult Pathology","heading":"2.1 Charcot","text":"","code":""},{"path":"adult-pathology.html","id":"definition","chapter":"2 Adult Pathology","heading":"2.1.0.1 Definition","text":"non infectious,destructive process culminating dislocations periarticular fractures patients peripheral neuropathy loss protective sensations0.1 29% incidence50% need one operation life time15-67% chance amputation","code":""},{"path":"adult-pathology.html","id":"clinical-features","chapter":"2 Adult Pathology","heading":"2.1.0.2 Clinical features","text":"PainLocal rise temparature >3-50 compared normalSwellingDeformity","code":""},{"path":"adult-pathology.html","id":"cahrcot-vs-infection","chapter":"2 Adult Pathology","heading":"2.1.0.3 Cahrcot vs Infection","text":"","code":""},{"path":"adult-pathology.html","id":"classification","chapter":"2 Adult Pathology","heading":"2.1.0.4 Classification","text":"","code":""},{"path":"adult-pathology.html","id":"eichenholtz","chapter":"2 Adult Pathology","heading":"2.1.0.4.1 Eichenholtz","text":"","code":""},{"path":"adult-pathology.html","id":"progression","chapter":"2 Adult Pathology","heading":"2.1.0.5 Progression","text":"0-1 6 months 2-3 12-14 months","code":""},{"path":"adult-pathology.html","id":"causes","chapter":"2 Adult Pathology","heading":"2.1.0.6 Causes","text":"Endocrine: DM, Renal failure, AlcoholInfection: Leprosy, syphilisNeurogenic: CP, Syrinx,Myelomeningocele, cord injuryIdiopathic","code":""},{"path":"adult-pathology.html","id":"theories","chapter":"2 Adult Pathology","heading":"2.1.0.7 Theories","text":"NeurotraumaticNeurovascular ( Autonomic dysfunction causing bone resorption)Inflammatory theory (Favored, injury lead inflammation activate RANK-RANKL pathway leading bone resorption)ADA, 2011 suggests hybrid theories","code":""},{"path":"adult-pathology.html","id":"clinical-examination","chapter":"2 Adult Pathology","heading":"2.1.0.8 Clinical examination","text":"","code":""},{"path":"adult-pathology.html","id":"look","chapter":"2 Adult Pathology","heading":"2.1.0.8.1 Look","text":"Stand patient look deformity. common Rocker bottom PlanovalgusWalk patient look Clawing also look foot wearSit patient look deformity, ulceration inflammation","code":""},{"path":"adult-pathology.html","id":"feel","chapter":"2 Adult Pathology","heading":"2.1.0.8.2 Feel","text":"Temperature, tenderness, pulse sensation","code":""},{"path":"adult-pathology.html","id":"move","chapter":"2 Adult Pathology","heading":"2.1.0.8.3 Move","text":"joints","code":""},{"path":"adult-pathology.html","id":"special-tests","chapter":"2 Adult Pathology","heading":"2.1.0.8.4 Special tests","text":"Silfverskiöld test, Vibration, offer probing ulcer","code":""},{"path":"adult-pathology.html","id":"management-principles","chapter":"2 Adult Pathology","heading":"2.1.0.9 management principles","text":"Stop inflammationProtect maintain foot architectureRelieve painArrest reverse de-mineralisationPrevent/limit deformityControl DMSuspect Charcot deformity associated inflammation, perepheral neuropathy without renal failureSuspected /c Charcot: always take weight bearing X Ray, negative take MRIImmediatly refer MDT","code":""},{"path":"adult-pathology.html","id":"mdt-approach","chapter":"2 Adult Pathology","heading":"2.1.0.10 MDT approach","text":"Non removable offloading deviceNo BisphosphonatesMonitor Foot Skin temperature assessment seriel xrays inflammation resolves","code":""},{"path":"adult-pathology.html","id":"when-will-you-say-that-inflammation-is-resolved","chapter":"2 Adult Pathology","heading":"2.1.0.11 When will you say that inflammation is resolved?","text":"Temperature difference < \\(2^0\\) feetSeriel xrays show progression","code":""},{"path":"adult-pathology.html","id":"diabetic-foot","chapter":"2 Adult Pathology","heading":"2.2 Diabetic foot","text":"Diabetes systemic disease causes - Neuropathy - Vasculopathy - Ulceration - DeformitiesHence requires MDT approach diabetic treatment. include Hospital based MDT Community based foot protection service","code":""},{"path":"adult-pathology.html","id":"assessment","chapter":"2 Adult Pathology","heading":"2.2.0.1 Assessment","text":"well diabetes controlled: HBA1CHow well diabetes controlled: HBA1CPresence neuropathy\nMotor: Deformities, intrinsic minus, weak TibAnt, MT head pressure\nSensory: Loss protective sensation (10g S-W monofilament, vibration 128hz)\nAutonomic: Dry skin, nail changes,increased vascular response trauma\nPresence neuropathyMotor: Deformities, intrinsic minus, weak TibAnt, MT head pressureSensory: Loss protective sensation (10g S-W monofilament, vibration 128hz)Autonomic: Dry skin, nail changes,increased vascular response traumaPresence Vasculitis\nABPI >0.45 triphasic flow dopplar\nTrC-O2 >30\nAbsolute toe pressure >40 mmHg\nPulse\nPresence VasculitisABPI >0.45 triphasic flow dopplarTrC-O2 >30Absolute toe pressure >40 mmHgPulsePresence Ulceration\nUlceration either infected non infected. ulcers, rule ischemia (vascular ulcer) Neuropathy.\nPresence UlcerationUlceration either infected non infected. ulcers, rule ischemia (vascular ulcer) Neuropathy.DeformitiesDeformities","code":""},{"path":"adult-pathology.html","id":"classification-1","chapter":"2 Adult Pathology","heading":"2.2.0.2 Classification","text":"SINBAD ulcerUniversity texas classificatio foot","code":""},{"path":"adult-pathology.html","id":"sinbad-classification","chapter":"2 Adult Pathology","heading":"2.2.0.2.1 SINBAD Classification","text":"SiteIschemiaNeuropathyBacterial infectionAreaDepth","code":""},{"path":"adult-pathology.html","id":"university-of-texas-classification","chapter":"2 Adult Pathology","heading":"2.2.0.2.2 University of Texas Classification","text":"","code":""},{"path":"adult-pathology.html","id":"management","chapter":"2 Adult Pathology","heading":"2.2.0.3 Management","text":"General: Prevention, education accomodative foot wear.Ulcer management depends whether ulcer infected .","code":""},{"path":"adult-pathology.html","id":"uninfected-ulcer-manaagement","chapter":"2 Adult Pathology","heading":"2.2.0.3.1 Uninfected ulcer manaagement","text":"ulcer uninfected first differentiate wheter neuropathic vascular ulcer. Neuropathic ulcersSeen metatarsal headsPunched outPainlessHealthy granulationPulse presentThere loss vibration sensation Treatment Total Contact Cast followed accomodative footwear. Vascular ulcersSeen wherePainfulPulse may absentRequires vascular team assessment angioplasty/bipass. followed TCC accomodative foot wear","code":""},{"path":"adult-pathology.html","id":"infected-ulcer-management","chapter":"2 Adult Pathology","heading":"2.2.0.3.2 Infected ulcer management","text":"ulcer ischemic, managed vascular teamOtherwise, local hospital team managing range appropriate antibiotics per culture Amputation.","code":""},{"path":"adult-pathology.html","id":"deformity-management","chapter":"2 Adult Pathology","heading":"2.2.0.4 Deformity management","text":"","code":""},{"path":"adult-pathology.html","id":"ac-presentations-that-need-surgery","chapter":"2 Adult Pathology","heading":"2.2.0.4.1 A/C presentations that need surgery","text":"Medical dislocation T-N joint causing plano valgus deformityDorsal dislocation T-N joint causing lateral rocker bottomInfection requiring drainage/sepsisIschemia/gangrene","code":""},{"path":"adult-pathology.html","id":"chronic-deformities","chapter":"2 Adult Pathology","heading":"2.2.0.4.2 Chronic deformities","text":"","code":""},{},{"path":"adult-pathology.html","id":"tuberculosis-of-locomotor-system","chapter":"2 Adult Pathology","heading":"2.3 Tuberculosis of Locomotor system","text":"total population patients tuberculosis, forget less important organs like head, chest abdomen, subset people locomotor system TB comes 1-2%. 50% spinal, 15% hip 10% knee. Rest patients joint area bone involvement.predominantly paucibacillary type, meaning, chances finding mycobacteria specimens near unlikely. make diagnosis difficult treatment trouble-sum.","code":""},{"path":"adult-pathology.html","id":"diagnosis","chapter":"2 Adult Pathology","heading":"2.3.0.1 Diagnosis","text":"approach diagnosis PaTeNDed.Pa-PainPa-PainTe-TendernessTe-TendernessN-NeurologyN-NeurologyDed-DeformityDed-DeformityParticular problem pain. Almost patients come orthopaedic surgeon pain. task filter small portion organic pain big collection mechanical somatic pains. One useful rule thumb isorganic pains increase period rest often associated rest pain night painThe moment see patient, especially associated localised tenderness, subtle neurological findings deformity, think 3 potential diseasesMalignancyMalignancyInfectionInfectionInflammatory diseasesInflammatory diseasesWe always suspect TB situation.TB spine can bePara-diskal –>Arterial spread (common)Para-diskal –>Arterial spread (common)Central –> VenousCentral –> VenousAnterior–>Sub-periostealAnterior–>Sub-periostealPosterior–>Unstable (rare)Posterior–>Unstable (rare)Taking baseline xray first investigation can quickly . ESR CRP got prognostic values. Contrast enhanced MRI, preferably Gadolinium best screening test available. MRI picture suggesting infection, take biopsy CT guidance. specimen sent forHPEHPEMycobacterium culturesMycobacterium culturesNAAT testNAAT testStainingStaining","code":""},{"path":"adult-pathology.html","id":"naat","chapter":"2 Adult Pathology","heading":"2.3.0.2 NAAT","text":"Specimen NAAT sent sterile container, saline chance drying. 2 specimens.CB-NAAT (Cartridge based) TRU-NAAT (Card based) two types tests available. recognised NTEP diagnosis TB. One important point specimen contain blood urine, can reduce sensitivity test. Overall solid tissue preferred liquid. test, apart diagnosis, helps identifying Rifampicin sensitivity. speciment resistant RIF, send second sample Genotypic/phenotypic drug resistant test. LPA (line probe analysis) rapid test can employed detect resistance first second line drugs.","code":""},{"path":"adult-pathology.html","id":"culture","chapter":"2 Adult Pathology","heading":"2.3.0.3 Culture","text":"culture medium choice MGIT (Mycobacterium Growth detection Tube). prone contamination, yields result 2-4 weeks. always co-culture LJ medium mitigate problem contamination.","code":""},{"path":"adult-pathology.html","id":"hpe","chapter":"2 Adult Pathology","heading":"2.3.0.4 HPE","text":"Pathologists look forEpitheloid cellsEpitheloid cellsGranulomaGranulomaLymphocytic infiltrationLymphocytic infiltration","code":""},{"path":"adult-pathology.html","id":"treatment","chapter":"2 Adult Pathology","heading":"2.3.0.5 Treatment","text":"ATT- 2HREZ + 10-16 HRE (16 spine)ATT- 2HREZ + 10-16 HRE (16 spine)ImmobilisationImmobilisationSurgerySurgery","code":""},{"path":"adult-pathology.html","id":"indications-for-surgery","chapter":"2 Adult Pathology","heading":"2.3.0.6 Indications for surgery","text":"Neurological complications, especially worsening medical managementNeurological complications, especially worsening medical managementNon neurological complicationsNon neurological complicationsNon neurological complications may warrant surgery includeM- Mass effect, mechanical instabilityM- Mass effect, mechanical instabilityD-DeformityD-DeformityR-ResistanceR-ResistanceTuli classification NeurologyNot aware weaknessNot aware weaknessAware weaknessAware weaknessIn extensionIn extensionIn flexionIn flexion","code":""},{"path":"adult-pathology.html","id":"follow-up","chapter":"2 Adult Pathology","heading":"2.3.0.7 Follow-up","text":"Weekly- Assessment neurologyWeekly- Assessment neurology3 monthly- X-Rays3 monthly- X-Rays6 monthly- MRI6 monthly- MRIFollow-2 years completion treatment\nFollow-2 years completion treatment","code":""},{"path":"diagrams-for-viva.html","id":"diagrams-for-viva","chapter":"3 Diagrams for viva","heading":"3 Diagrams for viva","text":"","code":""},{"path":"diagrams-for-viva.html","id":"action-potential","chapter":"3 Diagrams for viva","heading":"3.1 Action potential","text":"\nFigure 3.1: Action Potential\n","code":""},{"path":"diagrams-for-viva.html","id":"articular-cartilage","chapter":"3 Diagrams for viva","heading":"3.2 Articular cartilage","text":"\nFigure 3.2: Articular cartilage\n","code":""},{"path":"diagrams-for-viva.html","id":"femoral-head-supply","chapter":"3 Diagrams for viva","heading":"3.3 Femoral head supply","text":"\nFigure 3.3: Blood supply femoral head\n","code":""},{"path":"diagrams-for-viva.html","id":"brachial-plexus","chapter":"3 Diagrams for viva","heading":"3.4 Brachial Plexus","text":"\nFigure 3.4: Brachial Plexus\n","code":""},{"path":"diagrams-for-viva.html","id":"carpal-tunnel","chapter":"3 Diagrams for viva","heading":"3.5 Carpal Tunnel","text":"\nFigure 3.5: Carpal tunnel incision\n\nFigure 3.6: Carpal tunnel contents\n","code":""},{"path":"diagrams-for-viva.html","id":"cement","chapter":"3 Diagrams for viva","heading":"3.6 Cement","text":"\nFigure 3.7: Curing bone cement\n","code":""},{"path":"diagrams-for-viva.html","id":"motion-segment","chapter":"3 Diagrams for viva","heading":"3.7 Motion segment","text":"\nFigure 3.8: Motion segment\n","code":""},{"path":"diagrams-for-viva.html","id":"femoral-teardrop","chapter":"3 Diagrams for viva","heading":"3.8 Femoral teardrop","text":"\nFigure 3.9: Tear drop lines\n","code":""},{"path":"diagrams-for-viva.html","id":"spinal-cord","chapter":"3 Diagrams for viva","heading":"3.9 Spinal cord","text":"\nFigure 3.10: Spinal cord cross section\n","code":""},{"path":"diagrams-for-viva.html","id":"nerve","chapter":"3 Diagrams for viva","heading":"3.10 Nerve","text":"\nFigure 3.11: nerve\n","code":""},{"path":"clinical-audit.html","id":"clinical-audit","chapter":"4 Clinical audit","heading":"4 Clinical audit","text":"quality improvement tool evaluating improving patient care outcomes. achieved systematically reviewing current practices explicit criteria measuring impact change(s) introduced generate improvement.clinical audit process can described “Plan,” “,” “Study,” “Act” phases comprise audit cycle.\nFigure 3.1: Figure 1:audit cycle, showing 4 necessary steps complete audit cycle, planning audit (“Plan”), collection analysis data (“” “Study”) identifying steps leading towards improvement (“Act”). cycle intended repeated goal continuous improvement. Adapted Langley et al\n","code":""},{"path":"clinical-audit.html","id":"method","chapter":"4 Clinical audit","heading":"4.1 Method","text":"","code":""},{"path":"clinical-audit.html","id":"plan","chapter":"4 Clinical audit","heading":"4.1.1 Plan","text":"Identifying area certain standards need met.Setting evidence based standards quality improvement project derived Local level – .e. hospital derived, Regional level National levelThis stage identify data collected.","code":""},{"path":"clinical-audit.html","id":"do","chapter":"4 Clinical audit","heading":"4.1.2 Do","text":"Measurement clinical practice requires:population audit: predefined inclusion exclusion criteria.data collection tool.data collected must analysed implementing change.","code":""},{"path":"clinical-audit.html","id":"study","chapter":"4 Clinical audit","heading":"4.1.3 Study","text":"requires comparison current practice, collected stage 2 cycle (Measuring), best practice identifying areas change needs made.Changes made practice often line key areas clinical governance, can include:Education trainingClinical effectivenessRisk managementStaffing management","code":""},{"path":"clinical-audit.html","id":"act","chapter":"4 Clinical audit","heading":"4.1.4 Act","text":"requires maintenance changes practice line best practice standards. , necessitates adherence key components clinical governance.One fundamental parts clinical audit sustaining improvement re-audit. often referred completing cycle entails repeating stages clinical audit provide objective evidence improvement sustained.","code":""},{"path":"clinical-audit.html","id":"audit-is-not-research","chapter":"4 Clinical audit","heading":"4.2 Audit is not research","text":"Clinical audit differs clinical research.Clinical research focused establishing evidence base best practice.Clinical audit aims ensure best practice, identified clinical research, adhered standards met.","code":""},{"path":"research-methodology.html","id":"research-methodology","chapter":"5 Research Methodology","heading":"5 Research Methodology","text":"","code":""},{"path":"research-methodology.html","id":"p-value-and-ci","chapter":"5 Research Methodology","heading":"5.1 p-value and CI","text":"\nFigure 3.3: Histogram showing male female height ploted againt count\nAssume normally distributed population males females mean height 168.5444368cms 157.8109596cms respectively.can see mean difference height 10.7334772If measure entire population world, find mean height sex different? orwould find difference mean height zero?","code":""},{"path":"research-methodology.html","id":"how-to-answer-this-question","chapter":"5 Research Methodology","heading":"5.1.0.0.1 How to answer this question?","text":"","code":""},{"path":"research-methodology.html","id":"frequentist-method","chapter":"5 Research Methodology","heading":"5.1.0.1 Frequentist method","text":"Assume hypothetical world difference height sexes.repeated experiments find proportion times obtain difference observed means(ø) hypothetical world great greater difference observed real experiment.\nproportion time abbreviated p-value words p-value=P(ø/H), given null(H), probability data(ø)p-value answer question didn’t intend ask. ?","code":""},{"path":"research-methodology.html","id":"traditional-answers","chapter":"5 Research Methodology","heading":"5.1.0.2 Traditional Answers","text":"","code":""},{"path":"research-methodology.html","id":"fisher","chapter":"5 Research Methodology","heading":"5.1.0.2.1 Fisher","text":"Treat measure strength evidence. objectively satisfactory , p-value=P(ø/H)≠P(H/ø)","code":""},{"path":"research-methodology.html","id":"neyman-pearson-decision-framework","chapter":"5 Research Methodology","heading":"5.1.0.2.2 Neyman-Pearson decision framework","text":"experiment, need choose Null alternative, possibility two types errorsFalse Positive: Choosing alternative Null trueFalse Negative: Choosing Null alternative trueControl rate commit decision errors false positive type applying strict procedure experiment:researcher make decision. research, convention choose alternative hypothesis test result outside 95% mark normal curve. remaining 5% called œ. boundary approximately 1.96z, ie, 1.96 standard deviations away mean.Z-score numerical measurement describes value’s relationship mean group values. Z-score measured terms standard deviations mean. Z-score 0, indicates data point’s score identical mean score. Z-score 1.0 indicate value one standard deviation mean. Z-scores may positive negative, positive value indicating score mean negative score indicating mean.œ zone rejection null hypothesis z boundary acceptance rejection zones null hypothesis.refer statistical charts, p value z score ≤1.96 ≤0.05","code":""},{"path":"research-methodology.html","id":"so-the-decision-framework-is-to","chapter":"5 Research Methodology","heading":"5.1.0.2.3 So the decision framework is to","text":"Compute p-valueChoose Null p-value > αChoose alternative p-value <= αTypically α set 0.05Another important concept confidence interval","code":""},{"path":"research-methodology.html","id":"confidence-interval","chapter":"5 Research Methodology","heading":"5.2 Confidence Interval","text":"repeated sampling hypothetical world, 95% confidence intervals constructed way include true value mean difference.ranges fixed value x y either side zero,.e., x-0-y.0-x lower confidence limit 0+y upper confidence limit.","code":""},{"path":"research-methodology.html","id":"confidence-limit","chapter":"5 Research Methodology","heading":"5.2.0.0.1 Confidence limit","text":"sets boundary confidence interval generally taken 95%.confidence interval generally considered important p value givesStatistical significanceClinical significancePrecision","code":""},{"path":"research-methodology.html","id":"funnel-plot","chapter":"5 Research Methodology","heading":"5.3 Funnel plot","text":"Introduction","code":""},{"path":"research-methodology.html","id":"talking-the-talk","chapter":"5 Research Methodology","heading":"5.3.0.1 Talking the talk","text":"\nFigure 5.1: Funnel Plot\nDoctor,see ?called funnel plot simple scatterplot treatment effects (RR ) estimated individual studies (horizontal axis) precision studies represented standard error (SE).vertical dotted line shows estimated combined RR meta-analysis. diagonal dotted lines show range studies ideally distributed given size (thus precision) study. Thus larger (big sample size), precise (smaller standard error) studies closely distributed either side pooled effect smaller studies distributed widely giving classic inverted symmetrical funnel. studies distributed randomly (due sampling error) around combined RR estimate influence suggested.\nFigure 5.2: Assymetric Funnel Plot\nNow ?funnel plot shows trials scattered asymmetrically around pooled RR smaller trials reporting greater effect larger ones.Two possible explanations : smaller trials lower methodological quality tend overestimate true effect; publication bias led smaller negative trials remaining unpublished.\nFigure 5.3: Outliers, Funnel Plot\n, ?funnel plot displays % observed 30-day mortality rate operations Y-axis total number operations X-axis. practice lying line Y=1 surgeon performing close average, whereas practice lying Y=1 total number operations higher average.Important pointFunnel plot used detect publication bias well outliers","code":""},{"path":"research-methodology.html","id":"funnel-plot-1","chapter":"5 Research Methodology","heading":"5.3.0.2 Funnel plot","text":"common question FRCS(Tr & Orth) viva. understand concept, give thought basis statistical tool. Let us start base.","code":""},{"path":"research-methodology.html","id":"understand-the-concept","chapter":"5 Research Methodology","heading":"5.3.0.3 Understand the concept","text":"Mean, median, mode three kinds “averages.” many “averages” statistics, common.“mean” statistical “average,” add variables divide number variables.“median” “middle” value list variables. find median, variables listed numerical order smallest largest, may rewrite list can find median.“mode” value occurs often. variable list repeated, mode list.understand funnel plot also know statistical concepts   variance , standard deviation standard error mean.","code":""},{"path":"research-methodology.html","id":"variance","chapter":"5 Research Methodology","heading":"5.4 Variance","text":"sum average squared difference mean.eg: x~1, x~2, x~3, x~n list n number values, mean, x̄ = (x~n + x~1 )/n. Variance=Σ (x-x̄)^2/ (n-1).","code":""},{"path":"research-methodology.html","id":"standard-deviation","chapter":"5 Research Methodology","heading":"5.5 Standard deviation","text":"measure standardized dispersion data mean. calculated taking square root variance.Standard deviation σ = √∑, .e., standard deviation square root variance.Assume someone asked walk straight line point point b. individual steps taken person can equated standard deviation variance deviation path central line.\nFigure 5.4: walking variance sd\nσ sd Σ varianceUnlike standard deviation variance can identify outliers also shows spread data.","code":""},{"path":"research-methodology.html","id":"standard-error-of-meansem","chapter":"5 Research Methodology","heading":"5.6 standard error of mean(SEM)","text":"standard deviation sample mean population mean.Assume population 1000 members. order study average height population, select sample size. Also assume one scientist y started study sample size 50. repeated study n times. found time average height found study different. calculated mean value height n studies designated x̄~1. x̄~1 sample mean study.Another scientist z selected sample size 10 conducted n number similar study similarly also got sample mean, x̄~2. decided find actual population mean x̄ studying entire population. also calculated far x̄~1 x̄~2 deviate x̄. deviation x̄~1 found less x̄~2. deviation called Standard error meanwhen n increases, standard error mean decreases precision study increases.basis funnel plot.","code":""},{"path":"research-methodology.html","id":"funnel-plot-concepts","chapter":"5 Research Methodology","heading":"5.6.0.1 Funnel plot concepts","text":"representation SEM plotted true population mean effect line study graph. Smaller studies tend larger SEM larger studies smaller SEM. Hence plot assumes funnel shape. ideal world, funnel plot supposed form symmetrical “funnel.” case real world, various reasons.","code":""},{"path":"research-methodology.html","id":"uses-of-funnel-plot","chapter":"5 Research Methodology","heading":"5.6.0.2 Uses of funnel plot","text":"identify outliers. Eg: surgical resident’s performanceTo identify validity meta-analysis. asymmetrical funnel plot suggests potential problem results meta-analysis.","code":""},{"path":"research-methodology.html","id":"causes-of-asymmetrical-funnel-plot","chapter":"5 Research Methodology","heading":"5.6.0.3 Causes of asymmetrical funnel plot","text":"Reporting bias\nReporting bias\nPublication bias: Delayed reporting, language bias, duplication)\nSelective outcome reporting\nSelective analysis reporting\n\nReporting biasReporting bias\nPublication bias: Delayed reporting, language bias, duplication)\nSelective outcome reporting\nSelective analysis reporting\nReporting biasPublication bias: Delayed reporting, language bias, duplication)Selective outcome reportingSelective analysis reportingPoor methodology\nDesign\nAnalysis\nFraud\nPoor methodologyDesignAnalysisFraudHeterogeneityHeterogeneityChanceChance","code":""},{"path":"research-methodology.html","id":"heterogeneity","chapter":"5 Research Methodology","heading":"5.6.0.4 Heterogeneity","text":"Variations expected chancepredicts whether data different studies can combined meta-analysis obtain forest plot.","code":""},{"path":"research-methodology.html","id":"causes-1","chapter":"5 Research Methodology","heading":"5.6.0.4.1 Causes","text":"","code":""},{"path":"research-methodology.html","id":"detecting-heterogeneity","chapter":"5 Research Methodology","heading":"5.6.0.5 Detecting Heterogeneity","text":"Review table describing individual studies“eye ball test,” review forest plotReview statistical testsStatistical tests","code":""},{"path":"research-methodology.html","id":"statistical-tests-for-detecting-heterogeneity","chapter":"5 Research Methodology","heading":"5.6.0.6 Statistical tests for detecting heterogeneity","text":"Tests presence: Chi Square test, p>0.1 means study homogenousTests presence: Chi Square test, p>0.1 means study homogenousTest quantify: ^2\nmeasures % heterogeneity (≤25%—-low, 50%—-moderate, ≥75%—-high)\nTest quantify: ^2It measures % heterogeneity (≤25%—-low, 50%—-moderate, ≥75%—-high)","code":""},{"path":"research-methodology.html","id":"analysis-of-cause-of-heterogeneity","chapter":"5 Research Methodology","heading":"5.6.0.7 Analysis of cause of heterogeneity","text":"heterogeneity identified quantified, analyze find present","code":""},{"path":"research-methodology.html","id":"this-is-done-by","chapter":"5 Research Methodology","heading":"5.6.0.7.1 This is done by","text":"subgroup analysisMetaregression","code":""},{"path":"health-economics.html","id":"health-economics","chapter":"6 Health economics","heading":"6 Health economics","text":"","code":""},{"path":"health-economics.html","id":"impact-funds","chapter":"6 Health economics","heading":"6.1 Impact funds","text":"Let’s embark thought experiment involving two cities: Pharma City Social City, identical population 1,000 residents. cities, five individuals contracted novel disease characterized watery diarrhea, known Cholera. pharmaceutical company developed innovative treatment, named ORS, treatment course priced $84,000. Concurrently, another research identified root cause infection: contaminated water supply. Addressing water quality issue involves expense $420 per person. budget $420,000 disposal, face decision: allocate amount Pharma Impact Fund Pharma City Global Impact Fund Social City. city choose assist?","code":""},{"path":"references.html","id":"references","chapter":"References","heading":"References","text":"","code":""}]
